Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
26.7%
% of GDOC's 49 holdings also in FBT
40.0%
% of FBT's 31 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
BIOMARIN PHARMACEUTICAL INC | 15.8% | 3.6% | 3.6% |
 |
METTLER-TOLEDO INTERNATIONAL | 9.4% | 3.5% | 3.5% |
 |
GENMAB A/S SPONSORED ADR | 6.7% | 3.5% | 3.5% |
 |
ARGENX SE ADR | 4.6% | 3.4% | 3.4% |
|
EXACT SCIENCES CORP | 6.9% | 3.4% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to FBT
|
ELI LILLY & CO | 39.2% |
|
BOSTON SCIENTIFIC CORP | 24.3% |
 |
ASTRAZENECA PLC | 21.6% |
|
INTUITIVE SURGICAL INC | 20.1% |
|
INSULET CORP | 14.6% |
|
DEXCOM INC | 13.7% |
|
COOPER COS INC/THE | 13.7% |
|
ZIMMER HOLDINGS INC | 13.3% |
|
BIOGEN IDEC INC | 12.8% |
 |
CSL LIMITED | 12.7% |
GDOC Underweight Relative to FBT
 |
GRIFOLS SA-ADR | -3.9% |
|
IQVIA HOLDINGS INC | -3.7% |
|
QIAGEN NV | -3.6% |
 |
BIONTECH SE SPONSORED ADR | -3.6% |
|
IONIS PHARMACEUTICALS, INC. | -3.5% |
|
CHARLES RIVER LABORATORIES | -3.5% |
|
AGIOS PHARMACEUTICALS INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.4% |
|
EXELIXIS INC | -3.4% |
|
ACADIA PHARMACEUTICALS INC | -3.3% |